Keloid
https://en.wikipedia.org/wiki/Keloid
☆ Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa. relevance score : -100.0%
References
Keloid 29939676 NIH
Keloidi huundwa kutokana na uponyaji usio wa kawaida baada ya kuumia kwa ngozi au kuvimba. Sababu za kijeni na kimazingira huchangia ukuaji wao, huku viwango vya juu zaidi vya watu wenye ngozi nyeusi wa asili ya Kiafrika, Asia, na Rico. Keloidi hutokea wakati fibroblasts zinapofanya kazi kupita kiasi, huzalisha collagen nyingi, na kusababisha ukuaji wa kifurushi kikubwa cha kolajeni kisicho cha kawaida kinachojulikana kama keloidal collagen, pamoja na ongezeko la nyuzi nyuzi. Kliniki, keloidi huonekana kama vinundu thabiti, vya mpira, katika maeneo yaliyojeruhiwa hapo awali. Tofauti na makovu ya kawaida, keloidi huenea zaidi ya eneo la asili ya kiwewe. Wagonjwa wanaweza kupata maumivu, kuwasha, au kuchoma. Matibabu mbalimbali yanapatikana, ikiwa ni pamoja na sindano za steroid, cryotherapy, upasuaji, radiotherapy, na laser therapy.
Keloids result from abnormal wound healing in response to skin trauma or inflammation. Keloid development rests on genetic and environmental factors. Higher incidences are seen in darker skinned individuals of African, Asian, and Hispanic descent. Overactive fibroblasts producing high amounts of collagen and growth factors are implicated in the pathogenesis of keloids. As a result, classic histologic findings demonstrate large, abnormal, hyalinized bundles of collagen referred to as keloidal collagen and numerous fibroblasts. Keloids present clinically as firm, rubbery nodules in an area of prior injury to the skin. In contrast to normal or hypertrophic scars, keloidal tissue extends beyond the initial site of trauma. Patients may complain of pain, itching, or burning. Multiple treatment modalities exist although none are uniformly successful. The most common treatments include intralesional or topical steroids, cryotherapy, surgical excision, radiotherapy, and laser therapy.
Keloid treatments: an evidence-based systematic review of recent advances 36918908 NIH
Utafiti wa hivi karibuni unapendekeza kuwa jeli ya silicone au karatasi pamoja na sindano za corticosteroid ndizo matibabu ya awali yanayopendekezwa kwa keloid. Matibabu ya ziada kama vile intralesional 5-fluorouracil (5-FU), bleomycin, au verapamil pia yanaweza kuzingatiwa, ingawa ufanisi wake unatofautiana. Tiba ya laser, inapojumuishwa na sindano za corticosteroid au steroids za ndani chini ya uzuiaji, inaweza kuongeza ufanisi wa dawa. Kwa keloid zilizokaidi, upasuaji unaofuatiwa na tiba ya mionzi ya papo hapo umeonyesha kuwa wa ufanisi. Hatimaye, matumizi ya karatasi ya silicone na tiba ya shinikizo yameuthibitisha kupunguza uwezekano wa keloid kujirudia.
Current literature supports silicone gel or sheeting with corticosteroid injections as first-line therapy for keloids. Adjuvant intralesional 5-fluorouracil (5-FU), bleomycin, or verapamil can be considered, although mixed results have been reported with each. Laser therapy can be used in combination with intralesional corticosteroids or topical steroids with occlusion to improve drug penetration. Excision of keloids with immediate post-excision radiation therapy is an effective option for recalcitrant lesions. Finally, silicone sheeting and pressure therapy have evidence for reducing keloid recurrence.
Keloids: a review of therapeutic management 32905614 NIH
Kwa sasa, hakuna matibabu ya aina moja yanayohakikisha kiwango cha chini cha kujirudia kwa keloidi. Hata hivyo, chaguzi zinazopatikana, kama vile matumizi ya lesi ya steroids au mchanganyiko wa 5-fluorouracil na steroids, zinaonyesha matokeo mazuri. Utafiti wa siku zijazo unaweza kuangalia jinsi matibabu mapya, kama vile upandikizaji wa mafuta ya kiotomatiki au matibabu ya msingi wa seli, yanavyofanya kazi katika kudhibiti keloidi.
There continues to be no gold standard of treatment that provides a consistently low recurrence rate; however the increasing number of available treatments and synergistic combinations of these treatments (i.e., laser-based devices in combination with intralesional steroids, or 5-fluorouracil in combination with steroid therapy) is showing favorable results. Future studies could target the efficacy of novel treatment modalities (i.e., autologous fat grafting or stem cell-based therapies) for keloid management.
Scar Revision 31194458 NIH
Makovu ni sehemu ya kawaida ya mchakato wa uponyaji baada ya majeraha ya ngozi. Kwa kawaida, makovu yanapaswa kuwa gorofa, nyembamba, na kufanana na rangi ya ngozi. Sababu nyingi zinaweza kusababisha uponyaji mbaya wa jeraha, kama vile maambukizi, kupungua kwa mtiririko wa damu, ischemia, na kiwewe. Makovu ambayo ni mazito, meusi zaidi kuliko ngozi inayozunguka, au yanayosinyaa kupita kiasi, yanaweza kusababisha matatizo makubwa katika utendaji wa kimwili na afya ya kihisia.
Scars are a natural and normal part of healing following an injury to the integumentary system. Ideally, scars should be flat, narrow, and color-matched. Several factors can contribute to poor wound healing. These include but are not limited to infection, poor blood flow, ischemia, and trauma. Proliferative, hyperpigmented, or contracted scars can cause serious problems with both function and emotional well-being.
Kovu za keloid huonekana mara nyingi zaidi kwa watu wa asili ya Kiafrika, Asia, au Kihispania. Watu wenye umri kati ya miaka 10 na 30 wana uwezekano mkubwa wa kuendeleza keloid kuliko wazee.
Ingawa kwa kawaida hutokea kwenye tovuti ya jeraha, keloid pia inaweza kujitokeza bila sababu. Inaweza kutokea kwenye tovuti ya kutoboa na hata kutokana na kitu rahisi kama pimple au mswaki. Inaweza pia kusababishwa na chunuli kali, tetekuwanga, majeraha yanayorudiwa, mvutano mwingi wa ngozi wakati wa kufungwa kwa jeraha, au mwili wa kigeni kwenye jeraha.
Kovu za keloid zinaweza kutokea baada ya upasuaji. Hutokea zaidi katika maeneo kama kifua cha kati (sternotomia), mgongo na mabega (kawaida husababishwa na chunuli), na sehemu za masikio (kutokana na kutoboa masikio). Pia inaweza kutokea baada ya kutoboa mwili. Maeneo yanayojulikana ni masikio ya nje (earlobes), mikono, eneo la pelvis, na juu ya mfupa wa kola.
Matibabu yanayopatikana ni tiba ya shinikizo, gel ya silikoni, triamcinolone acetonide ya ndani ya vidonda, upasuaji wa kufyatua, mionzi, tiba ya leza, Interferon, 5‑FU, na ukataji wa upasuaji.
○ Matibabu
Makovu ya hypertrophic yanaweza kuboreka kwa sindano 5 hadi 10 za intralesional steroid kwa muda wa mwezi mmoja.
#Triamcinolone intralesional injection
Tiba ya laser inaweza kujaribiwa kwa erithema inayohusishwa na kovu, lakini sindano za triamcinilone zinaweza pia kuboresha erithema kwa kubana kovu.
#Dye laser (e.g. V-beam)